c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial

Overview of attention for article published in BMC Medicine, February 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 9,408 followers.

An exploratory biomarker study of the phase 3 ICON7 trial studying c-MET/VEGFR-2 co-localisation impacts on survival following #bevacizumab therapy in epithelial #ovariancancer Read it here: https://t.co/rII7IQXBQU https://t.co/iLyLtHwRNw

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.